⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15686117 | 0.80 | CYP11B1 (0.46) | — | |
| SCHEMBL6073432 | 0.77 | — | — | |
| SCHEMBL2728918 | 0.75 | CYP2A6 (0.47) | — | |
| SCHEMBL4582687 | 0.75 | MKNK1 (0.62) | — | |
| SCHEMBL12009180 | 0.73 | CYP11B1 (0.48) | — | |
| SCHEMBL13662376 | 0.73 | ATM (0.35) | — | |
| SCHEMBL8925031 | 0.73 | CYP11B1 (0.37) | — | |
| SCHEMBL10350035 | 0.71 | CA2 (0.38) | — | |
| SCHEMBL30505582 | 0.69 | CA2 (0.40) | — | |
| SCHEMBL28095891 | 0.69 | HCAR2 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 855 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120132832-A | Double-function catalyst for synthesizing saturated acid ester by unsaturated acid or/and anhydride esterification-hydrogenation coupling reaction and application thereof | 上海师范大学 | 2025-06-13 | — | — | CN | claimed |
| CN-113754590-B | Preparation method of rosuvastatin calcium intermediate | 浙江乐普药业股份有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-113841572-A | Taro cultivation method | 南通科技职业学院 | 2021-12-28 | — | — | CN | claimed |
| CN-113046734-A | Bivalent palladium complex solution and preparation method and application thereof | 上海天承化学有限公司 | 2021-06-29 | — | — | CN | claimed |
| CN-109134438-B | 1-phenazinyl (phenyl) (5-pyrimidinyl) methanol compound and preparation method and application thereof | 长江大学 | 2020-10-09 | — | — | CN | claimed |
| CN-110982883-A | High-throughput single-cell genome 5-hydroxymethylpyrimidine single-molecule visual analysis method | 西安交通大学 | 2020-04-10 | — | — | CN | claimed |
| CN-106008362-B | A kind of preparation method of pyrimidine derivatives | 杰达维（上海）医药科技发展有限公司 | 2018-08-10 | — | — | CN | claimed |
| JP-2011524881-A | — | — | 2011-09-08 | — | — | JP | claimed |
| EP-2307385-A1 | 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES | Novartis AG (CH) | 2011-04-13 | — | — | EP | claimed |
| CN-101935836-A | Surface treatment process of reddened copper foil for high-grade FR-4 copper-clad plate | SHANDONG JINBAO ELECTRONIC CO LTD | 2011-01-05 | — | — | CN | claimed |
| US-20100121052-A1 | Novel compounds for treating proliferative diseases | JAIN RAMA | 2010-05-13 | — | — | US | claimed |
| WO-2009153313-A1 | 2 -ARYLAMINOQUINAZOLINES FOR TREATING PROLIFERATIVE DISEASES | NOVARTIS AG (CH) | 2009-12-23 | — | — | WO | claimed |
| JP-56005466-A | — | — | None | — | — | JP | disclosed |
| US-20260125367-A1 | CANCER TREATMENTS TARGETING CANCER STEM CELLS | REMEDY PLAN, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12590062-B2 | PD-1/PD-L1 inhibitors | GILEAD SCIENCES, INC. (US) | 2026-03-31 | — | — | US | disclosed |
| US-12581252-B2 | Substituted pyrrolo[3,4-b]pyridines as PI3K-α inhibitors | RELAY THERAPEUTICS, INC. (US) | 2026-03-17 | — | — | US | disclosed |
| US-3967949-A | Fluoroalkoxyphenyl-substituted nitrogen heterocycles as plant stunting agents | ELI LILLY AND COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3956301-A | Process for bromination of pyrimidine | ELI LILLY AND COMPANY (US) | 1976-05-11 | — | — | US | disclosed |
| US-3869456-A | Synthesis of 5-pyrimidinecarbinols | LILLY CO ELI | 1975-03-04 | — | — | US | disclosed |
| US-3869456-A | Synthesis of 5-pyrimidinecarbinols | LILLY CO ELI | 1975-03-04 | — | — | US | disclosed |